Access cutting-edge stomach cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access stomach cancer specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related stomach cancer treatment provided free
This pilot clinical trial studies genetic analysis-guided irontecan hydrochloride dosing of modified fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin (mFOLFIRINOX) in treating patients with gastroesophageal or stomach cancer that has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by
Sponsor: University of Chicago
Check if you qualify for this stomach cancer clinical trial in Chicago, IL
If you're searching for stomach cancer treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stomach cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.